Standardized breast cancer mortality rate compared to the general female population of iran

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 11, 2012, Pages 5525-5528

  Haghighat, S ^a,b   Akbari, M E ^c   Ghaffari, S ^d   Yavari, P ^a,e  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AVICENNA RESEARCH INSTITUTE   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Social Security Organization   (Iran)

^e Department of Health and Community Medicine ^*  (Iran)

Author keywords

Breast Cancer; Iran.; Mortality rate; Smr; Survival

Indexed keywords

EID: 84874083022     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.11.5525     Document Type: Article

References (21)

1. Akbari ME, Khayamzadeh M, Khoshnevis S, et al (2008). Five and ten years survival in breast cancer patients mastectomies vs. breast conserving surgeries personal experience. Iranian J Cancer Prev, 1, 53-7.
2. Cabanes A, Vidal E, Perez-Gomez B, et al. (2009). Age-specific breast, uterine and ovarian cancer mortality trends in Spain: changes from 1980 to 2006. Cancer Epidemiol, 33, 169-75.
3. Cancer Office MOH (2009). Iranian Annual Report of Cancer Registration 2007-2008, Cancer Office CDC, Deputy for Health. Ministry of Hlth and Medical Educ of Iran
4. Chen HH, Thurfjell E, Duffy SW, Tabar L (1998). Evaluation by Markov chain models of a non-randomised breast cancer screening programme in women aged under 50 years in Sweden. J Epidemiol Community Hlth, 52, 329-35.
5. Christopher IL (2010). Breast Cancer Epidemiology. New York Springer.
6. Death Office MOH (2007). Iranian Annual Report of Death Registration 2006 Deputy for Health, Ministry of Health and Medical Educ of Iran.
7. Demicheli R, Ardoino I, Boracchi P, et al. (2010). Recurrence and mortality according to estrogen receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast. BMC Cancer, 10, 656.
8. Erbas B, Hyndman RJ, G DM (2007). Forecasting age-specific breast cancer mortality using functional data models. Stat Med, 26, 458-70.
9. Finkelstein DM, Muzikansky A and Schoenfeld DA (2003). Comparing survival of a sample to that of a standard population. J Natl Cancer Inst, 95, 1434-9.
10. Hirte L, Nolte E, Bain C, McKee M (2007). Breast cancer mortality in Russia and Ukraine 1963-2002: an age-period-cohort analysis. Int J Epidemiol, 36, 900-6.
11. Jatoi I, Chen BE, Anderson, Rosenberg PS (2007). Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol, 25, 1683-90.
12. Johnson ES, Faramawi MF, Sall M, Choi KM (2011). Cancer and noncancer mortality among American seafood workers. J Epidemiol, 21, 204-10.
13. Khadivi R, Harrirchi I, Khosravi Z, Akbari ME (2008). Ten year breast cancer screening and follow up in 52200 women in Shahre-Kord, Iran (1997-2006).Iranian J Cancer Prev, 1, 73-6.
14. Mousavi Naiini M, Mofid B, Mohebi H, et al (2009). "Comparison the effect of two methods of surgery in breast cancer recurrence, Metastasis and survival. Kosar Medical J, 14, 89-94.
15. Mousavi S, Montazeri A, Mohaghegh M, et al (2007). Breast cancer in iran: an epidemiological review. Breast J, 13, 383-391.
16. Movahedi M, Haghighat SH, Khayamzadeh M, et al (2011). Survival rate of breast cancer based on geographical variaation in Iran, a national study." RCJ (in press).
17. Tabar L, Fagerberg G, Day NE, et al (1992). Natural history of breast cancer. Lancet, 339, 1108.
18. Will BP, Berthelot JM, Le Petit C, et al. (2000). Estimates of the lifetime costs of breast cancer treatment in Canada. Eur J Cancer, 36, 724-35.
19. Yaghmaii S, Banihashemi G, Ghorbani R (2007). Breast cancer Survavial and correlated factors in Emdad Hospital of Semnan. Semnan Medical Univ J, 9(2).
20. Yavari p, Abadi A and Mehrabi Y (2003). Mortality and changing epidemiological trends in Iran during 1979-2001. Hakim, 6, 8-14.
21. Zahl PH, Maehlen J (2005). Reduction in mortality from breast cancer: decrease with screening was marked in younger age group. BMJ, 330, 1024 author reply 1025.